These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3132174)

  • 1. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Biochem Pharmacol; 1988 Jun; 37(11):2255-8. PubMed ID: 3132174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cytotoxicity of sodium valproate on primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Neuropediatrics; 1988 Aug; 19(3):158-61. PubMed ID: 3146709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.
    Aires CC; van Cruchten A; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Hepatol; 2011 Aug; 55(2):426-34. PubMed ID: 21147182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-carnitine supplementation on acute valproate intoxication.
    Murakami K; Sugimoto T; Woo M; Nishida N; Muro H
    Epilepsia; 1996 Jul; 37(7):687-9. PubMed ID: 8681902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation.
    Sugimoto T; Araki A; Nishida N; Sakane Y; Woo M; Takeuchi T; Kobayashi Y
    Epilepsia; 1987; 28(4):373-7. PubMed ID: 3113926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-carnitine on ketone bodies, redox state and free amino acids in the liver of hyperammonemic mice.
    O'Connor JE; Costell M; Míguez MP; Portolés M; Grisolía S
    Biochem Pharmacol; 1987 Oct; 36(19):3169-73. PubMed ID: 3663232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycine on valproate toxicity in rat hepatocytes.
    Vance MA; Gray PD; Tolman KG
    Epilepsia; 1994; 35(5):1016-22. PubMed ID: 7925144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
    Elhamri M; Ferrier B; Martin M; Baverel G
    J Pharmacol Exp Ther; 1993 Jul; 266(1):89-96. PubMed ID: 8331578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.
    Nishida N; Sugimoto T; Araki A; Woo M; Sakane Y; Kobayashi Y
    Pediatr Res; 1987 Nov; 22(5):500-3. PubMed ID: 3120144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiketonemic and antiketogenic actions of carnitine in vivo and in vitro in rats.
    Yeh YY
    J Nutr; 1981 May; 111(5):831-40. PubMed ID: 7229733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketogenic effects of low and high levels of carnitine during total parenteral nutrition in the rat.
    Böhles HJ; Akcetin Z
    Am J Clin Nutr; 1987 Jul; 46(1):47-51. PubMed ID: 3111240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.
    Gidal BE; Inglese CM; Meyer JF; Pitterle ME; Antonopolous J; Rust RS
    Pediatr Neurol; 1997 May; 16(4):301-5. PubMed ID: 9258962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues.
    Rozas I; Camiña MF; Paz JM; Alonso C; Castro-Gago M; Rodriguez-Segade S
    Biochem Pharmacol; 1990 Jan; 39(1):181-5. PubMed ID: 2105093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-carnitine on urea synthesis following acute ammonia intoxication in mice.
    Costell M; O'Connor JE; Míguez MP; Grisolía S
    Biochem Biophys Res Commun; 1984 May; 120(3):726-33. PubMed ID: 6329182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation.
    Schiavo A; Maldonado C; Vázquez M; Fagiolino P; Trocóniz IF; Ibarra M
    Eur J Pharm Sci; 2023 Apr; 183():106399. PubMed ID: 36740101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y; Sakane Y
    Neuropediatrics; 1990 Nov; 21(4):187-90. PubMed ID: 2290478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.